Bioinformatics Barcelona (BIB), launched in 2014, constitutes a regionally-based multi-center bioinformatics platform as part of a joint initiative of the Government of Catalonia and the Fundcació Bancària “la Caixa”. VHIO is a member of the BIB network incorportating research centers and clinical institutes, universities, pharmaceutical and IT companies.
BIB aims to establish itself as a central point and facilitator of new initiatives to respond to the needs of the bioinformatics community. By capitalizing on the critical mass of like-minded, internationally renowned researchers, currently available IT infrastructures, and an entire network of biotech companies, the platform will strive to become an international reference within the bioinformatics field.
To help it deliver on this objective as well as enhance the visibility of catalan bioinformatic potential, BIB has just launched its website. On behlalf of BIB we invite you to discover more by visiting:http://bioinformaticsbarcelona.eu.
VHIO Omics & Technology Platforms
VHIO´s suite of cutting-edge core technology platforms enable us to apply next-generation whole-genome sequencing for precision oncology. By sequencing panels of genes or entire genomes in cancer patients, we can identify specific molecular risk factors and gauge the potential efficacy of specific agents for individual patients.
In parallel, these technologies (Hiseq2500, MiSeq, nCounter Nanostring), accelerate our research enabling the identification of mechanisms of resistance to targeted therapies, the study of clonal populations, and definition of novel therapeutic opportunities based on mutation profiles.
For more information about VHIO´s technologies, prescreening program as well as its Cancer Genomics and Oncology Data Science (ODysSey) Groups contact: Amanda Wren, Director of Communications, Vall d´Hebron Institute of Oncology (VHIO), Email: awren@vhio.net, Tel. +34 695207886.
